Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lust

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The Lancet. Gastroenterology & Hepatology|December 10, 2021
Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trialJulien D Schulberg, Emily K Wright, Bronte A Holt, et al.
Journal of Crohn'S & Colitis|January 5, 2025
A new protocolized treatment strategy optimizing medical and surgical care leads to improved healing of Crohn's perianal fistulasMichael De Gregorio, Leon S Winata, Imogen Hartley, et al.
Internal Medicine Journal|September 5, 2024
6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapyNatalie Yu, Tanya Lee, Daniel Tassone, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The Lancet. Gastroenterology & Hepatology|December 10, 2021
Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trialJulien D Schulberg, Emily K Wright, Bronte A Holt, et al.
Journal of Crohn'S & Colitis|January 5, 2025
A new protocolized treatment strategy optimizing medical and surgical care leads to improved healing of Crohn's perianal fistulasMichael De Gregorio, Leon S Winata, Imogen Hartley, et al.
Internal Medicine Journal|September 5, 2024
6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapyNatalie Yu, Tanya Lee, Daniel Tassone, et al.
Pageof 3